Three healthcare stocks I'm buying: Mako, ResMed and Centene

Author: Bob Freedland

Covestor model: Healthcare

The Healthcare Model had a relatively flat month in January, as this group of stocks underperformed the S&P 500. I continue to work to identify the strongest collection of stocks in this evolving area of medical care and related industries.

Two stocks within this model continue to perform well:  Intuitive Surgical (ISRG), maker of the DaVinci robotic surgical platform, and HealthStream (HSTM). I have added Mako (MAKO) back into the mix hoping that the company will also benefit from the robotic surgical approach, this time in the Orthopedic field.

ResMed (RMD) has been returned to the portfolio as recent results suggest this company is starting to represent true value. The stock has underperformed for quite a while.

Another promising addition to this model is Centene (CNC), which is already making a positive contribution to the model's performance.

I continue to be committed to working this model to improve performance and reduce trading activity as longer-term winners prove themselves.

Covestor Ltd. is a registered Investment Advisor. Covestor Investment Management licenses investment strategies from its Model Managers to establish investment models. The commentary here is provided as general and impersonal information and should not be construed as recommendations or advice. Information from Model Managers and third-party sources deemed to be reliable but not guaranteed. Past performance is no guarantee of future results. Transaction histories for investment models available upon request. Additional important disclosures are available here. For information about Covestor and its services, go to our website, Covestor Investment Management or contact Covestor Client Services at (866) 825-3005, x703.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MarketsHealth CareHealth Care Equipment
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!